Blog: Research

Stem Cells in Mouse Hair Seen to Aid Growth of ‘Dense’ Myelin Sheaths Around Nerve Cells, Study Reports

2 May 2019

Source Multiple Sclerosis News Today: A subset of stem cells in hair follicles, called melanocytes, appear to do more than just give rise to mature melanocytes, cells that help to determine hair colour. Those melanocyte stem cells, or McSCs, that carry the CD34 protein were found in hair follicles from mice to differentiate into glial cells and support myelin production, a study reports.

New £1.8m research to explore cognitive screening and rehabilitation in multiple sclerosis

10 April 2019

Source University of Nottingham: A new £1.85 million research study led by Professor Roshan das Nair at the Institute of Mental Health aims to develop a new computerised screening tool to detect the “invisible” cognitive impairments that can appear early in the life of a person living with multiple sclerosis (MS).

Anyone taking Plegridy?

10 April 2019

Source MS Trust: NICE will be assessing Plegridy to decide whether it should continue to be prescribed by the NHS in England. We’ll be telling NICE why we think it should be an option. If you are taking Plegridy we’d really like to know what you think of it, your experiences good and bad.

Mitochondria and progressive MS

10 April 2019

Source MS Society: Small but mighty, mitochondria provide the energy that busy nerve cells need to survive.

We spoke with mitochondria expert Dr Don Mahad, from the University of Edinburgh, about what makes them so special - and what goes wrong in MS.

Mitochondria and progressive MS

‘I’m interested in energy production and demand in the brain and spinal cord, and especially how this changes in progressive MS.’ It’s the mitochondria that generate the bulk of this...

T20K in Good Position to Become Preventive MS Treatment, Cyxone Says

10 April 2019

Source Multiple Sclerosis News Today: T20K, Cyxone‘s lead compound for treating multiple sclerosis (MS), seems able to prevent or slow disease progression, according to data from preclinical studies. Based on these findings, the company is confident that T20K might become a prophylactic (preventive) medication for MS in the near future.

How do families affected by MS manage health information

25 March 2019

Source MS Trust: Couples and families develop their own unique ways of dealing with an MS diagnosis. A recent UK study looked at how different family units affected by MS, cope with receiving MS health information.

In this study, UK researchers wanted to understand how couples and families affected by MS cope with health information.

The researchers analysed interviews with 77 people affected by MS – 12 people with MS, 49 partners or spouses, 7 parents, 5 children, 2 siblings...

Research shows hot chocolate could help reduce fatigue

6 March 2019

Source MS Society: We know around 90% of people with MS experience fatigue, which can severely impact their quality of life.

Innovative clinical research using robotic technology to improve balance & mobility for people living with MS

4 March 2019

A ground-breaking clinical research trial is inviting people living with Multiple Sclerosis (MS) to take part in the evaluation of a balance exercise program using a robotic walking device.

Continuous Use of Gilenya for Up to 3 Years Can Lead to 50% Drop in Annual Relapse Rates, Real-world Study Says

15 February 2019

Source Multiple Sclerosis News Today: Multiple sclerosis (MS) patients who began treatment with Gilenya (fingolimod) and stayed with it continuously showed a more than 50 percent reduction in annual relapse rates, a real-world study following these people for up to three years found.

Masterswitch discovered in body's immune system

12 February 2019

Source Science Daily: Scientists have discovered a critical part of the body's immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.

Pages

Category

Archive